HCA Healthcare, Inc. (HCA) is a publicly traded Healthcare sector company. As of May 21, 2026, HCA trades at $390.80 with a market cap of $93.79B and a P/E ratio of 20.74. HCA moved -1.85% today. Year to date, HCA is -16.99%; over the trailing twelve months it is +2.75%. Its 52-week range spans $289.98 to $556.52. Analyst consensus is buy with an average price target of $523.14. Rallies surfaces HCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes HCA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $390.80 |
| Market Cap | $93.79B |
| P/E Ratio | 20.74 |
| EPS | $19.25 |
| Dividend Yield | 0.78% |
| 52-Week High | $556.52 |
| 52-Week Low | $289.98 |
| Volume | 3.78K |
| Avg Volume | 0 |
| Revenue (TTM) | $64.97B |
| Net Income | $6.09B |
| Gross Margin | 0.00% |
14 analysts cover HCA: 0 strong buy, 10 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $523.14.